Ho KY - Search Results

1

The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects.

Ho KY, Weissberger AJ, Stuart MC, Day RO, Lazarus L. Ho KY, et al. Clin Endocrinol (Oxf). 1989 Apr;30(4):335-45. doi: 10.1111/j.1365-2265.1989.tb00431.x. Clin Endocrinol (Oxf). 1989. PMID: 2598470

2

Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.

Ho KY, Weissberger AJ, Marbach P, Lazarus L. Ho KY, et al. Ann Intern Med. 1990 Feb 1;112(3):173-81. doi: 10.7326/0003-4819-112-3-173. Ann Intern Med. 1990. PMID: 2404445

3

The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system.

Ho KY, Weissberger AJ. Ho KY, et al. Metabolism. 1990 Feb;39(2):133-7. doi: 10.1016/0026-0495(90)90065-k. Metabolism. 1990. PMID: 2405233

4

Quantification of urinary growth hormone (GH) excretion by centrifugal ultrafiltration and radioimmunoassay: appraisal of the relationship between 24 h urinary GH and mean 24 h serum GH levels in normal and abnormal states of GH secretion.

Weissberger AJ, Ho KY, Stuart MC. Weissberger AJ, et al. Among authors: ho ky. Clin Endocrinol (Oxf). 1989 Jun;30(6):687-98. doi: 10.1111/j.1365-2265.1989.tb00275.x. Clin Endocrinol (Oxf). 1989. PMID: 2591065

5

Resolution of apparent growth hormone-dependent growth failure during puberty: a case report.

Weissberger AJ, Ho KY, Lazarus L. Weissberger AJ, et al. Among authors: ho ky. Horm Res. 1989;32(4):148-50. doi: 10.1159/000181278. Horm Res. 1989. PMID: 2696721

6

Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.

Ho KY, Weissberger AJ. Ho KY, et al. Clin Endocrinol (Oxf). 1994 Jul;41(1):75-83. doi: 10.1111/j.1365-2265.1994.tb03787.x. Clin Endocrinol (Oxf). 1994. PMID: 8050134

7

Secretory patterns of growth hormone according to sex and age.

Ho KY, Weissberger AJ. Ho KY, et al. Horm Res. 1990;33 Suppl 4:7-11. doi: 10.1159/000181576. Horm Res. 1990. PMID: 2245973

8

The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.

Ho KY, Smythe GA, Lazarus L. Ho KY, et al. Clin Endocrinol (Oxf). 1985 Jul;23(1):7-16. doi: 10.1111/j.1365-2265.1985.tb00177.x. Clin Endocrinol (Oxf). 1985. PMID: 3928213 Clinical Trial.

9

Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.

Ho KY, Smythe GA, Lazarus L. Ho KY, et al. Clin Endocrinol (Oxf). 1984 Jan;20(1):53-63. doi: 10.1111/j.1365-2265.1984.tb00059.x. Clin Endocrinol (Oxf). 1984. PMID: 6420095

10

Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism.

Ho KY, Smythe GA, Duncan M, Lazarus L. Ho KY, et al. J Clin Endocrinol Metab. 1984 Jan;58(1):128-33. doi: 10.1210/jcem-58-1-128. J Clin Endocrinol Metab. 1984. PMID: 6689678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

637 results

Search Page

Filters